Underdown Brian J.

CIK 00015263352 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001526335

Recent Transactions

50 trades

Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2021-03-19−2,500→ 0 total
Exercise/Conversion
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2021-03-19$1.50/sh+2,500→ 2,500 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2020-12-30+75,000→ 75,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2020-04-23+75,000→ 75,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2019-10-21+75,000→ 75,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2019-05-23+50,000→ 50,000 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−2,500→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+500→ 500 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−6,250→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+2,500→ 2,500 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−35,000→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+6,250→ 6,250 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−500→ 0 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−25,000→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+25,000→ 25,000 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29−25,000→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+25,000→ 25,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-29+35,000→ 35,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-08-05+75,000→ 75,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2018-02-02+100,000→ 100,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2017-09-19+50,000→ 50,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2017-04-26+35,000→ 35,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2016-11-09+25,000→ 25,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2016-06-19+25,000→ 25,000 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-11-11−50,000→ 0 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-11-11−2,500→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-11-11+2,500→ 2,500 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-11-11−7,500→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-11-11+7,500→ 7,500 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-11-11−2,500→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-11-11+2,500→ 2,500 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-11-11−20,000→ 0 total
Award
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-11-11+20,000→ 20,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-11-11+50,000→ 50,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-09-02+50,000→ 50,000 total
Award
ARGOS THERAPEUTICS INC
Stock Option (right to buy)
2015-06-17+5,500→ 16,500 total
Award
ARGOS THERAPEUTICS INC
Stock Option (right to buy)
2015-06-17+5,500→ 5,500 total
Award
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2015-01-11+20,000→ 20,000 total
Other
Vistagen Therapeutics, Inc.$VTGN
Warrant for Common Stock
2014-03-19+50,000→ 50,000 total
Conversion
ARGOS THERAPEUTICS INC
Series B Preferred Stock
2014-02-12−13,131→ 0 total
Conversion
ARGOS THERAPEUTICS INC
Series D Preferred Stock
2014-02-12−582,769→ 0 total
Conversion
ARGOS THERAPEUTICS INC
Series E Preferred Stock
2014-02-12−569,990→ 0 total
Conversion
ARGOS THERAPEUTICS INC
Common Stock
2014-02-12+582,769→ 639,085 total
Conversion
ARGOS THERAPEUTICS INC
Series C Preferred Stock
2014-02-12−43,185→ 0 total
Conversion
ARGOS THERAPEUTICS INC
Common Stock
2014-02-12+569,990→ 1,209,075 total
Conversion
ARGOS THERAPEUTICS INC
Common Stock
2014-02-12+13,131→ 13,131 total
Conversion
ARGOS THERAPEUTICS INC
Common Stock
2014-02-12+43,185→ 56,316 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock
2014-02-12$8.00/sh+40,497→ 1,249,572 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2013-12-20+50,000→ 50,000 total
Disposition to Issuer
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2013-12-20−10,000→ 0 total

Companies

Recent Filings

Address

C/O VISTAGEN THERAPEUTICS, INC. 384 OYSTER POINT BLVD., NO 8.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov